CAU
This asset is not currently listed on any markets available through Pearler. The information on this page may be inaccurate or out of date.
Cronos Australia Limited
🇦🇺 ASX
👑 Overview
📈 Performance
💰 Dividends
💵 Cost
🍃 Esg
🤓 Advanced
👨👩👧👦 Community
📈
N/A
Annual Growth
5 years average annual capital growth
💰
1.68%
Annual dividend yield
Based on the most recent dividend
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
23
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Cronos Australia Limited
📈 Performance
Price History
+120.41%
1M
All Time
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💰 Dividends
Payouts
💰 Annual Dividend Yield*
1.68%
💰 Annual Dividend Earnings Per $1,000 invested**
$16.81
💰 Most Recent Dividend Franked Percentage Estimate
100.00%
💰 Average Dividend Franked Percentage Estimate
100.00 %
💰 Dividend reinvestment
* Based on the most recent dividend
** Calculated by multiplying the most recent dividend yield by $1,000
Dividend History
1Y
5Y
10Y
Graph
Table
Year
Yearly Dividend Earnings Per Share
Franking Estimate
2025
$0.00
0.00%
2024
$0.00
0.00%
2023
$0.00
0.00%
2022
$0.01
100.00%
2021
$0.00
0.00%
2020
$0.00
0.00%
2019
$0.00
0.00%
2018
$0.00
0.00%
2017
$0.00
0.00%
2016
$0.00
0.00%
💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.54
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in CAU
0
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in CAU
792 days
CAU investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
👶 Age of investors
18 - 25
26 - 34
35 - 90
🙋 Legal gender of investors
Female
Male
Pearlers who invest in CAU also invest in...
Vitura Health Ltd. operates as a medicinal cannabis company. The firm through its wholly owned subsidiary, CDA Health Pty Ltd, operates businesses, such as Burleigh Heads Cannabis and CDA Clinics. Burleigh Heads Cannabis operates the prescriber, patient, pharmacy and supplier online platform, CanView, which sells and distributes approximately 200 product stock-keeping units (SKUs) within Australia from 30 international and domestic medicinal cannabis producers. CDA Clinics undertakes telehealth consultations with patients seeking access to medicinal cannabis. Its portfolio of brands includes CanView, Burleigh Heads Cannabis, CDA Clinics, Cannadoc and Adaya. The firm owns 75.5% of Cannadoc Health Pty Ltd, a medicinal cannabis clinic business that undertakes nationwide telehealth consultations with patients seeking access to medicinal cannabis.
📊 Share price
$0.32 AUD
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
📊 Share price
$90.18 AUD
NULL AUSTRALIA
NULL BETA
VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.
📊 Share price
$57.36 AUD
NULL GLOBAL
NULL SMART BETA
A200.AX was created on 2018-05-07 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The ETF currently has 2975.21m in AUM and 200 holdings. A200.AX aims to track the performance of an index (before fees and expenses) comprising 200 of the largest companies by market capitalisation listed on the ASX.
📊 Share price
$120.79 AUD
NULL AUSTRALIA
NULL BETA
Incannex Healthcare Ltd. is a clinical stage pharmaceutical development company, which engages in the research and development associated with medicinal cannabinoid and psychedelic pharmaceutical products and therapies. The company is headquartered in Melbourne, Victoria. The company went IPO on 2007-05-23. The firm is engaged in the research and development associated with medicinal cannabinoid and psychedelic pharmaceutical products and therapies. The firm targets five indications: obstructive sleep apnea (OSA), traumatic brain injury and concussion (TBI), rheumatoid arthritis (RA), inflammatory bowel disease (IBD) and inflammatory lung conditions. Its drug candidates include IHL-42X, IHL-216A, Psilocybin-assisted psychotherapy for general anxiety disorder (Psi-GAD) and IHL-675A. Its IHL-42X is a cannabinoid combination product for treatment of OSA. Its IHL-675A comprises a combination of hydroxychloroquine and CBD for prevention and treatment of inflammatory lung conditions, rheumatoid arthritis and inflammatory bowel diseases. IHL-216A is a cannabinoid combination product for the treatment of TBI. The company is investigating the use of psilocybin-assisted psychotherapy to treat GAD.
📊 Share price
$0.12 AUD
Want more shares? Try these...
Carnavale Resources Ltd. engages in the development and exploration of mineral properties. The company is headquartered in Perth, Western Australia. The company went IPO on 2007-03-15. The firm is engaged in acquiring and exploring advanced exploration and development projects, prospective for strategic minerals. The firm is focused on its gold projects in Western Australia. The firm intends to acquire new opportunities associated with the electric battery sector and other new-age disruptive technologies, together with the gold, nickel, and copper resource sector. Its Kookynie Gold Project is located in the central portions of the historic Kookynie Mining Centre 20 kilometers (km) south of Leonora. The firm has 80% ownership in the Ora Banda South Project which covers an area of approximately 25 square kilometers (KM2), located 65km northwest of Kalgoorlie in the Yilgarn Craton, Western Australia. Its Grey Dam Ni-Co Project is located near Kurnalpi approximately 90km northeast of Kalgoorlie, West Australia. The firm also owns Barracuda Ni Cu PGE Project.
📊 Share price
$0.00 AUD
Catapult Group International Ltd. engages in the development and supply of wearable athlete tracking and analytics solutions. The company is headquartered in Prahan, Victoria. The company went IPO on 2014-12-19. The firm operates through three segments: Performance & Health, Tactics & Coaching and Media & Other. Its Performance & Health segment is engaged in the design, development, and supply of wearable technology and athlete monitoring software solutions to sports teams, athletes, and the prosumer market. Its Tactics & Coaching segment is engaged in the design, development, and supply of video analysis, editing, and publishing software solutions to sports teams. Its Media & Other segment provides media licensing, athlete management, and professional services to customers. The firm also focused on providing digital and video analytic software solutions to elite sports teams globally. The firm operates through its subsidiary, Catapult Sports Inc.
📊 Share price